Back
Ultragenyx Pharmaceutical Vs. Madrigal Pharmaceuticals Industry Stock Comparison
Sell
43
RARE
Ultragenyx Pharmaceutical
Last Price:
42.51
Seasonality Move:
12.29%
Buy
61
MDGL
Madrigal Pharmaceuticals
Last Price:
216.08
Seasonality Move:
-8.39%
Sell
43
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $41.12. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $211.73. The Score for MDGL is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- MDGL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $41.12
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $211.73
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MDGL is experiencing selling pressure, which indicates risk of future bearish movement.
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.38 | Sell |
Relative Strength Index (14 RSI): | 36.17 | Sell |
Chaikin Money Flow: | -526969 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.16 - 45.34) | Sell |
Bollinger Bands (100): | (43.31 - 49.39) | Sell |
MDGL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -5.9 | Sell |
Relative Strength Index (14 RSI): | 45.18 | Sell |
Chaikin Money Flow: | -254611 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (202.77 - 229.47) | Sell |
Bollinger Bands (100): | (211.39 - 251.49) | Sell |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 41.46 | Sell |
20-day SMA: | 42.72 | Sell |
50-day SMA: | 45.61 | Sell |
200-day SMA: | 42.06 | Sell |
8-day EMA: | 41.51 | Sell |
20-day EMA: | 42.79 | Sell |
50-day EMA: | 44.59 | Sell |
200-day EMA: | 44.26 | Sell |
MDGL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 213.56 | Sell |
20-day SMA: | 211.43 | Buy |
50-day SMA: | 235.63 | Sell |
200-day SMA: | 201.57 | Buy |
8-day EMA: | 211.8 | Sell |
20-day EMA: | 216.08 | Sell |
50-day EMA: | 224.86 | Sell |
200-day EMA: | 215.85 | Sell |
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.46 per share, an increase next quarter of $0.08 per share, an increase this year of $0.87 per share, and an increase next year of $1.24 per share.
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $2.35 per share, an increase next quarter of $1.27 per share, a decrease this year of $9.09 per share, and an increase next year of $10.64 per share.
Ultragenyx Pharmaceutical Technical Analysis
May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Madrigal Pharmaceuticals Technical Analysis
May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |